October 23, 2018 PRINCETON, N.J. & OR AKIVA, Israel--(BUSINESS WIRE)--Regentis Biomaterials today announced it has expanded the SAGE clinical trial of GelrinC™ for the treatment of articular cartilage damage in the knee to 11 U.S. sites. GelrinC is an investigational device being evaluated as a treatment to help the body regrow cartilage in the knee. Articular cartilage
Seattle, Oct. 22, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global collagen meniscus implant market was valued at US$ 358.8 million in 2017 and is projected to exhibit a CAGR of 5.4% over the forecast period (2018–2026). To know the latest trends and insights prevalent in this market, click the link below:
Lund, Sweden, 08:00 CET, 22 October 2018 -BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, announces that it has started selling CERAMENT® BVF direct via its own US distributor network. Emil Billbäck, BONESUPPORT’s CEO said “The launch of our own US distribution network is a key strategic milestone as we work towards
HOLLAND, Mich., Oct. 22, 2018 /PRNewswire/ -- Shoulder Innovations, an emerging leader in the development of shoulder replacement systems, announced today it has closed a $2.5 million round of Series A equity funding led by Ann Arbor-based Michigan Angel Fund, Grand Rapids-based Wakestream Ventures, Genesis Innovation Group, cultivate(MD) and other equity holders. "It is impressive that the team at Shoulder Innovations has developed truly cutting-edge
SUNNYVALE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), a global technology leader in robotic-assisted, minimally invasive surgery, today announced financial results for the quarter ended September 30, 2018. Q3 Highlights Worldwide da Vinci procedures grew approximately 20% compared with the third quarter of 2017, driven primarily by growth in U.S.
WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new RESPONSE 4.5/5.0mm System for treating smaller stature younger patients with complex scoliosis. The system represents the
SAN DIEGO, Oct. 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its Board of Directors has named J. Christopher Barry to succeed Gregory T. Lucier as chief executive officer (CEO) effective November 5, 2018. Mr. Barry will join the NuVasive Board of Directors; Mr. Lucier
(Helsinki, October 18, 2018) – SYNOSTE Ltd, a Finnish medical device company creates smart solutions for patient-friendly bone-lengthening and bone-deformation correction. The company has raised over five million euros to start clinical investigations and to develop new clinical applications. SYNOSTE’s patented technology platform provides the basis for further disruptive changes in the treatment of congenital, trauma- and
October 18, 2018 HUNTLEY, Ill.--(BUSINESS WIRE)--Centric Medical, a division of Life Spine®, Inc., which focuses on developing surgical implants for the treatment of lower distal extremity pathology, announced today That the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the SATURN External Fixation System which consists of rings, struts, threaded rods,
ORLANDO, Fla., Oct. 18, 2018 /PRNewswire/ -- The Orthopaedic Implant Company ("OIC") launched its Semi-Extended Instrumentation for the OIC Tibial Nail from Gaylord Palms Convention Center in Orlando, Florida, at the 2018 Annual Meeting of the Orthopaedic Trauma Association (OTA). "The OIC IM Nail System brings OR efficiency and value to a whole new level," said Itai Nemovicher, President and
